Diagnostics

  • Rapid prostate cancer test could help reach underserved men

    Researchers from Cornell University have developed a portable, rapid prostate cancer screening kit that could provide early warning to populations with a higher incidence of prostate cancer. The proof-of-concept test uses a test strip and a small reader to quantify a marker of prostate cancer, called prostate-specific antigen (PSA), from a drop of blood in [...]

  • Interview: Helping cancer patients access potentially lifesaving testing and treatment

    More than 60 per cent of cancer patients are missing out on potentially life-saving treatments because their physicians aren't able to provide them with all the information they need. Patient immersion platform Swellter is working to bridge the gap between laboratory and pharmaceutical companies so they can easily share relevant and potentially transformative diagnostic and [...]

  • Biomarkers licensing deal could make early cancer detection more accurate

    Mainz Biomed, a molecular genetics diagnostic company specialising in the early detection of cancer has entered into a technology rights agreement with Socpra Sciences Santé Et Humaines S.E.C. The agreement will give Mainz access to a portfolio of novel mRNA biomarkers for potential future integration into ColoAlert, the Mainz Biomed's detection test for colorectal cancer [...]

  • Online STI testing service extended

    The Republic of Ireland's home Sexually Transmitted Infection (STI) testing service has been extended to counties Donegal, Leitrim and Sligo.   People over the age of 17 with an address in these counties can now order an STI test through the online platform. Those who require follow-up or treatment will be directed to participating STI clinics. Online [...]

  • Extending cervical cancer screening wait ‘could cost lives’, campaigners warn

    The period between routine cervical cancer screenings has been extended from every three years to every five years in Wales for women and people with a cervix aged 25 to 49. Health bosses say the decision is due to the success of human papillomavirus (HPV) testing, which was introduced in Wales in 2018. However, campaigners [...]

  • Lateral flow specialist secures £1m investment

    Wales-based medtech firm Bond Digital Health has secured a £1m cash injection to support its plans for growth. The Cardiff-headquartered company, which has developed a data capture and management system for lateral flow diagnostic tests, raised the investment through its existing shareholders. The investment included equity funding of £350,000 from the Development Bank of Wales, with [...]

  • Elizabeth Holmes verdict: Former Theranos CEO convicted of fraud

    Elizabeth Holmes, the founder of blood-testing startup Theranos has been found guilty on four of 11 charges of fraud. A jury convicted her on two counts of wire fraud and two counts of conspiracy to commit fraud after seven days of deliberation following a three-month trial. Journalists inside the courtroom said the 37-year-old showed little [...]

  • Call for government to address lateral flow testing supply

    The Royal Pharmaceutical Society is calling on the government to address rapid lateral flow testing supply issues amid the surge in COVID-19 cases caused by the Omicron variant. Current rules in England allow anyone who has tested positive to cut their self-isolation from 10 days to seven if they have negative LFTs on days six and seven. [...]

  • Strategy for universal COVID test

    Russian researchers have developed a strategy to create a cheap and rapid COVID-19 test based on isothermal amplification. Julia Makarova, associate professor at the National Research University Higher School of Economics (HSE) in Russia saidthis strategy will make it possible to create universal test systems for any of the COVID-19 variants. "The virus mutates quite [...]

  • Graphene-based neural probes improve detection of epileptic brain signals

    Research has found that tiny graphene neural probes can be used safely to greatly improve our understanding of the causes of epilepsy. The research shows that unique flexible brain probes can be used to record pathological brain signals associated with epilepsy with excellent fidelity and high spatial resolution. Dr Rob Wykes of the University of [...]